Status:
COMPLETED
Study of Vitamin D Supplementation to Male HIV Sero-positive Patients
Lead Sponsor:
Hvidovre University Hospital
Conditions:
HIV Seropositive
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
The investigators want to investigate if HIV sero-positive males benefit from vitamin D supplementation. The study runs in 16 weeks and the participants are treated with one of three placebo controlle...
Eligibility Criteria
Inclusion
- male
- HIV-positive
- at least 18 years old
- receiving HiglyActiveAntiRetroviral Therapy (HAART)
Exclusion
- hypercalcemia
- tuberculosis
- osteoporosis or other bone disease
- cancer with bone metastasis
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00990678
Start Date
April 1 2008
End Date
January 1 2011
Last Update
September 17 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. of endocrinology, Hvidovre Hospital
Copenhagen, Denmark, 2450